Xiaobin Yuan
Impact in
-
- Lung Cancer Treatments and Mutations
- Renal cell carcinoma treatment
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Renal cell carcinoma treatment 3
- Co-authors
- James C. M. Hwang (1 shared paper)David Forehand (1 shared paper)Charles L. Goldsmith (1 shared paper)Dongwen Wang (8 shared papers)Lieming Ding (4 shared papers)Xuhui Zhang (7 shared papers)Fenlai Tan (2 shared papers)Yinxiang Wang (1 shared paper)
- Journals
- PLoS ONE (3 papers)BMC Urology (2 papers)Molecular Therapy — Oncolytics (1 paper)Pharmacology (1 paper)Journal of Endourology (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaobin Yuan
27 papers receiving 313 citations
Peers
Comparison fields: 5 of 71
- Pulmonary and Respiratory Medicine 86
- Genetics 27
- Hematology 25
- Oncology 50
- Cancer Research 27
Countries citing papers authored by Xiaobin Yuan
This map shows the geographic impact of Xiaobin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Yuan more than expected).
Fields of papers citing papers by Xiaobin Yuan
This network shows the impact of papers produced by Xiaobin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Yuan. The network helps show where Xiaobin Yuan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 90 | |
| 2 | 2015 | 34 | |
| 3 | 2020 | 33 | |
| 4 | 2015 | 27 | |
| 5 | 2007 | 22 | |
| 6 | 2022 | 19 | |
| 7 | Studies on tabellae indigo naturalis in treatment of psoriasis. | 1982 | 16 |
| 8 | 2015 | 11 | |
| 9 | 2015 | 7 | |
| 10 | 2020 | 7 | |
| 11 | 2011 | 6 | |
| 12 | 2013 | 6 | |
| 13 | Highly differentiated squamous cell carcinoma arising from a suprapubic cystostomy tract in a patient with transplanted kidney. | 2015 | 6 |
| 14 | 2011 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2013 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2025 | 4 | |
| 19 | 2018 | 2 | |
| 20 | 2021 | 2 |
About Xiaobin Yuan
Xiaobin Yuan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 29 papers that have together received 319 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers), Renal cell carcinoma treatment (3 papers), Pituitary Gland Disorders and Treatments (3 papers), Adrenal and Paraganglionic Tumors (3 papers), HER2/EGFR in Cancer Research (2 papers), Colorectal Cancer Surgical Treatments (2 papers) and Pediatric Urology and Nephrology Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (86 citations), Genetics (27 citations), Hematology (25 citations), Oncology (50 citations) and Cancer Research (27 citations). Xiaobin Yuan has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include James C. M. Hwang, David Forehand, Charles L. Goldsmith, Dongwen Wang, Lieming Ding, Xuhui Zhang, Fenlai Tan, Yinxiang Wang, Yuankai Shi and Yan Sun. Their work appears in journals such as PLoS ONE, BMC Urology, Molecular Therapy — Oncolytics, Pharmacology and Journal of Endourology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.